These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3127238)

  • 1. The mycobacterial cell-wall as target for antimycobacterial drugs. I--Synthesis and activity of some diphenylalkylanalogues of mycolic acids.
    Leysen DC; Haemers A; Blanchaert L; Van Assche I; Bollaert W; Schoenmaekers K; Pattyn SR
    Farmaco Sci; 1987 Nov; 42(11):823-31. PubMed ID: 3127238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.
    Cavicchioli M; Leite CQ; Sato DN; Massabni AC
    Arch Pharm (Weinheim); 2007 Oct; 340(10):538-42. PubMed ID: 17912678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wall biosynthesis: a possible site of action for new antimycobacterial drugs.
    Draper P
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):527-32. PubMed ID: 6399069
    [No Abstract]   [Full Text] [Related]  

  • 4. [Structure of mycobacterial constituents: relation to immunologic activity].
    Lederer E
    Ann Microbiol (Paris); 1978 Jan; 129(1):91-3. PubMed ID: 655528
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemical structure of mycobacterial cell wall].
    Petit JF
    Ann Microbiol (Paris); 1978 Jan; 129(1):39-48. PubMed ID: 350116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
    Bergmann KE; Cynamon MH; Welch JT
    J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads.
    West NP; Cergol KM; Xue M; Randall EJ; Britton WJ; Payne RJ
    Chem Commun (Camb); 2011 May; 47(18):5166-8. PubMed ID: 21384024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell-based screening system for detection of inhibitors toward mycobacterial cell wall core.
    Gao P; Guan Y; Song D; Xiao C
    J Antibiot (Tokyo); 2009 Jun; 62(6):315-8. PubMed ID: 19444301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and analysis of Mycobacterium tuberculosis mycolic acids.
    Vilchèze C; Jacobs WR
    Curr Protoc Microbiol; 2007 Jun; Chapter 10():Unit 10A.3. PubMed ID: 18770604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between inhibitory effect of quinolones and mycolic acid metabolism in mycobacteria.
    Patil MA; Katoch VM; Venkatesan K; Sharma VD; Shivannavar CT; Kanaujia GV; Agrawal BM
    Indian J Lepr; 1992; 64(3):331-40. PubMed ID: 1431322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthesis and antimycobacterial action of lipophilic substituted 2,4-diamino-5-benzylpyrimidines].
    Hachtel G; Haller R; Seydel JK
    Arzneimittelforschung; 1988 Dec; 38(12):1778-83. PubMed ID: 3149896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characterization of fatty acids and mycolic acid degradation products in mycobacterial species of major incidence in Argentina].
    Zerbini E; Cardoso M; Sequeira M; Taher H; Santi N; Larpin D; Latini O; Tonarelli G
    Rev Argent Microbiol; 1997; 29(4):184-94. PubMed ID: 9472140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimycobacterial activity of novel 1,3-dimethylisocyanurate derivatives.
    Shulaeva MM; Fattakhov SG; Saifina LF; Chestnova RV; Valijev RSh; Mingaleev DN; Voloshina AD; Reznik VS
    Eur J Med Chem; 2012 Jul; 53():300-7. PubMed ID: 22578509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.
    Alahari A; Trivelli X; Guérardel Y; Dover LG; Besra GS; Sacchettini JC; Reynolds RC; Coxon GD; Kremer L
    PLoS One; 2007 Dec; 2(12):e1343. PubMed ID: 18094751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of antimicrobial agents against mycobacteria.
    Casal M; Rodríguez F; Gutierrez J; Ruíz P; Villalba R
    Drugs Exp Clin Res; 1988; 14(12):741-5. PubMed ID: 3150951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual inhibition of mycobacterial fatty acid biosynthesis and degradation by 2-alkynoic acids.
    Morbidoni HR; Vilchèze C; Kremer L; Bittman R; Sacchettini JC; Jacobs WR
    Chem Biol; 2006 Mar; 13(3):297-307. PubMed ID: 16638535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cell wall mycolic acid biosynthesis in acid-fast bacteria. I. Temperature-induced changes in mycolic acid molecular species and related compounds in Mycobacterium phlei.
    Toriyama S; Yano I; Masui M; Kusunose E; Kusunose M; Akimori N
    J Biochem; 1980 Jul; 88(1):211-21. PubMed ID: 7410334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and identification of mycolic acids in Mycobacterium leprae and Mycobacterium lepraemurium.
    Kusaka T; Kohsaka K; Fukunishi Y; Akimori H
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):406-16. PubMed ID: 7042604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.